When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - CytoDyn to launch pilot study of leronlimab for HIV PrEP
CytoDyn Inc
CytoDyn (OTCQB:CYDY)announces that it plans to conduct a five-subject pilot study evaluating leronlimab in HIV-infected patients who require bone marrow transplantation. The CCR5-blocking antibody will be used during the peri-transplant period to mimic a CCR5-deficient donor aimed at achieving HIV cure.
More news on: CytoDyn Inc., Healthcare stocks news,